David Stanton
Stock Analyst at Jefferies
(4.25)
# 1,445
Out of 4,609 analysts
225
Total ratings
50%
Success rate
13%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $28.80 → $29.40 | $21.56 | +36.36% | 18 | Aug 5, 2026 | |
| ASX: COH Cochlear Limited | Downgraded: Hold | $137.00 → $128.40 | $125.99 | +1.91% | 19 | Jul 28, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $39.20 → $40.80 | $9.37 | +335.43% | 11 | Jul 28, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $108.00 → $119.00 | $132.36 | -10.09% | 24 | Jul 28, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $2.80 → $3.00 | $2.23 | +34.53% | 16 | Jul 28, 2026 | |
| ASX: HLS Healius Limited | Maintained: Hold | $0.45 → $0.38 | $0.42 | -8.43% | 17 | Jul 28, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Hold | $192.60 → $195.80 | $177.99 | +10.01% | 3 | Jul 28, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $34.50 → $39.80 | $44.32 | -10.20% | 12 | Jul 28, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $5.00 → $5.60 | $2.68 | +108.96% | 12 | Jul 28, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $22.60 → $23.00 | $22.24 | +3.42% | 21 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.50 → $3.70 | $2.23 | +65.92% | 9 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.80 → $0.83 | $0.70 | +18.57% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.40 → $29.00 | $15.04 | +92.82% | 23 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $3.30 | $2.99 | +10.37% | 17 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.10 → $0.04 | $0.05 | -13.04% | 8 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.61 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.53 | n/a | 3 | Apr 8, 2021 |
Neuren Pharmaceuticals Limited
Aug 5, 2026
Maintained: Buy
Price Target: $28.80 → $29.40
Current: $21.56
Upside: +36.36%
Cochlear Limited
Jul 28, 2026
Downgraded: Hold
Price Target: $137.00 → $128.40
Current: $125.99
Upside: +1.91%
Clinuvel Pharmaceuticals Limited
Jul 28, 2026
Maintained: Buy
Price Target: $39.20 → $40.80
Current: $9.37
Upside: +335.43%
CSL Limited
Jul 28, 2026
Maintained: Hold
Price Target: $108.00 → $119.00
Current: $132.36
Upside: -10.09%
Mesoblast Limited
Jul 28, 2026
Maintained: Buy
Price Target: $2.80 → $3.00
Current: $2.23
Upside: +34.53%
Healius Limited
Jul 28, 2026
Maintained: Hold
Price Target: $0.45 → $0.38
Current: $0.42
Upside: -8.43%
Pro Medicus Limited
Jul 28, 2026
Maintained: Hold
Price Target: $192.60 → $195.80
Current: $177.99
Upside: +10.01%
Ramsay Health Care Limited
Jul 28, 2026
Maintained: Hold
Price Target: $34.50 → $39.80
Current: $44.32
Upside: -10.20%
Clarity Pharmaceuticals Ltd
Jul 28, 2026
Maintained: Buy
Price Target: $5.00 → $5.60
Current: $2.68
Upside: +108.96%
Sonic Healthcare Limited
Jul 28, 2026
Maintained: Hold
Price Target: $22.60 → $23.00
Current: $22.24
Upside: +3.42%
Jul 28, 2026
Maintained: Buy
Price Target: $3.50 → $3.70
Current: $2.23
Upside: +65.92%
Jul 28, 2026
Maintained: Buy
Price Target: $0.80 → $0.83
Current: $0.70
Upside: +18.57%
Jul 21, 2026
Maintained: Buy
Price Target: $27.40 → $29.00
Current: $15.04
Upside: +92.82%
May 5, 2026
Maintained: Buy
Price Target: $3.05 → $3.30
Current: $2.99
Upside: +10.37%
Mar 13, 2026
Downgraded: Hold
Price Target: $2.10 → $0.04
Current: $0.05
Upside: -13.04%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $15.61
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $15.53
Upside: n/a